PSA testing for prostate cancer
Prof Robert McLachlan* MBBS, FRACP, PhD
Director, Andrology Australia
DEBATE about the merits and harms of the PSA test for prostate cancer persists, and there is still no consensus on using the test in men without a history of the disease. This causes significant confusion for doctors and for men.
As the country’s peak body on male reproductive health, Andrology Australia has chosen not to add to the confusion but to make a modest attempt to review and summarise the current guidelines and position statements, and clarify the areas of agreement and the points of difference.